Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioPortfolio's Approved Drugs Database

Sanctura

Trospium Chloride

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Press Releases About Sanctura:

BioPortfolio Logo
Endo to Present at Bank of America and Merrill Lynch 2009 Health Care Conference 6th May, 2009 Endo Pharmaceuticals
CHADDS FORD, Pa., May 6 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) announced today that it will present at the Bank of America and Merrill Lynch 2009 Health Care Conference on
Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show 28th April, 2009 Endo Pharmaceuticals
Long-term Data Presented at AUA Annual Meeting CHICAGO, April 28 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today released new long-term clinical trial data in men with
Endo Pharmaceuticals Appoints Dr. Nancy Hutson to Board of Directors 30th March, 2009 Endo Pharmaceuticals
CHADDS FORD, Pa., March 30 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) announced today the appointment of Nancy J. Hutson, Ph.D., to the company's board of directors. Dr.
Endo Pharmaceuticals Completes Acquisition of Indevus Pharmaceuticals 23rd March, 2009 Endo Pharmaceuticals
CHADDS FORD, Pa., March 23 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced the successful completion of its acquisition of Indevus Pharmaceuticals, Inc. Endo acquired
Barr Reports Second Quarter 2008 GAAP Earnings of $0.52 Per Share; Adjusted Earnings of $0.64 Per Share 7th August, 2008 Barr Pharmaceuticals, Inc.
MONTVALE, N.J., Aug. 7 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL) today reported net earnings of $57 million, or $0.52 per share, on revenues of $779 million for the quarter

Companies working in the area of Sanctura from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

Indevus Pharmaceuticals

We acquire, develop and commercialize products for multiple therapeutic areas, with a primary commitment to urology, gynecology and men's health. Our robust clinical-stage pipeline has the potential...
www.indevus.com/        View full profile
Thumbshot

This page has been viewed 26 times
Recent Search Terms used to find this page: .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Sanctura across BioPortfolio, or for Sanctura Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.